Business
Therma Bright Prepares Launch of Digital Cough Screening and Data Collection Smartphone Application
Toronto, Ontario--(Newsfile Corp. - March 23, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBR...
About this update from Therma Bright Inc.
[{"type":"text","content":"Therma Bright Prepares Launch of Digital Cough Screening and Data Collection Smartphone ApplicationToronto, Ontario--(Newsfile Corp. - March 23, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (\"Therma\" or the \"Company\"), developer and investor in a range of leading-edge, proprietary diagnostic and medical device technologies, is pleased to announce that the Company and AI4LYF are preparing to launch DCT, its digital cough data collection and screening smartphone application. On February 16, 2023, Therma Bright announced that it acquired the exclusive worldwide licensing rights to market and sell products based on AI4LYF's Digital Cough Technology (\"DCT\"). This proprietary mobile app is an AI-enabled software application that can be used by individuals to record and collect cough sounds anywhere, any time by using a smartphone. Using AI-machine learning technology, DCT can detect the subtle and specific signatures of a variety of respiratory diseases through changes in cough features. \"Initially Therma Bright will make the smartphone application available through healthcare practitioners to be used as a general educational tool, so individuals become more aware of the nature and frequency of their cough. In the second phase, cough samples will be collected from patients with confirmed respiratory diseases,\" Dr. Ali Imran, founder for AI4LYF shared.In preliminary studies completed by AI4LYF, the team has been able to accurately identify subjects with certain respiratory conditions from their cough sounds, which validated the robustness of the AI machine learning technology. Several studies by other researchers have shown that cough severity is correlated with disease activity in asthma and a range of other respiratory diseases,3 making cough sounds an attractive biomarker candidate for respiratory disease severity. Out of these respiratory diseases, COPD alone affects more than 300 million people around the world. \"Although coughing is traditionally quantified via self- or parent-reporting in the form of questionnaires, the technological advances made by AI4LYF will allow for more sophisticated and more accurate cough monitoring and analysis methods,\" added Dr. Ali Imran.\"After discussions with United States Food & Drug Administration (FDA) and Health Insurance Portability and Accountability Act (HIPPA) expe...